Osaic Holdings’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,690
| Closed | -$228K | – | 7725 |
|
|
2024
Q2 | $228K | Sell |
6,690
-537
| -7% | -$18.5K | ﹤0.01% | 3432 |
|
|
2024
Q1 | $253K | Sell |
7,227
-388
| -5% | -$14.2K | ﹤0.01% | 3488 |
|
|
2023
Q4 | $289K | Sell |
7,615
-7,645
| -50% | -$164K | ﹤0.01% | 3633 |
|
|
2023
Q3 | $280K | Buy |
15,260
+7,180
| +89% | +$150K | ﹤0.01% | 3744 |
|
|
2023
Q2 | $210K | Sell |
8,080
-285
| -3% | -$6.66K | ﹤0.01% | 3855 |
|
|
2023
Q1 | $158K | Hold |
8,365
| – | – | ﹤0.01% | 4059 |
|
|
2022
Q4 | $206K | Sell |
8,365
-480
| -5% | -$14.1K | ﹤0.01% | 3820 |
|
|
2022
Q3 | $159K | Sell |
8,845
-200
| -2% | -$3.6K | ﹤0.01% | 3967 |
|
|
2022
Q2 | $102K | Sell |
9,045
-525
| -5% | -$7.72K | ﹤0.01% | 4414 |
|
|
2022
Q1 | $213K | Buy |
9,570
+300
| +3% | +$7.66K | ﹤0.01% | 3982 |
|
|
2021
Q4 | $405K | Sell |
9,270
-1,400
| -13% | -$56K | ﹤0.01% | 3264 |
|
|
2021
Q3 | $355K | Hold |
10,670
| – | – | ﹤0.01% | 3379 |
|
|
2021
Q2 | $294K | Buy |
10,670
+6,970
| +188% | +$145K | ﹤0.01% | 3535 |
|
|
2021
Q1 | $74K | Buy |
3,700
+1,800
| +95% | +$52.6K | ﹤0.01% | 4587 |
|
|
2020
Q4 | $63K | Hold |
1,900
| – | – | ﹤0.01% | 4403 |
|
|
2020
Q3 | $34K | Buy |
+1,900
| New | +$34.4K | ﹤0.01% | 4589 |
|
Osaic Holdings's INBX Position: Q3 2024 in Review
Osaic Holdings sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2024, closing a stake of 6,690 shares — an estimated $228K sold.
Osaic Holdings first reported a position in INBX in Q3 2020 and held it in 16 quarters. The position peaked at $405K in Q4 2021. 0 funds tracked by Wall St. Rank hold INBX as of Q3 2024.
- Osaic Holdings reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 6,690 Inhibrx, Inc. Common Stock shares in Q3 2024, an estimated $228K.
- Osaic Holdings first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 16 quarters.
- Osaic Holdings's Inhibrx, Inc. Common Stock position peaked at $405K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.